 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - FENNEC PHARMACEUTICALS Inc (FENC)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-12-12 Purchase | 2017-12-14 4:15 pm | FENNEC PHARMACEUTICALS Inc | FENC | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 294,115 | $8.5 | $2,499,978 | 3,225,694 (Direct) | View |
| 2014-08-29 Purchase | 2018-03-29 4:45 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 82,666 | $2.4815 | $205,132 | 1,324,794 (Indirect Direct) | View |
| 2014-08-29 Purchase | 2018-03-29 4:47 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 189,800 | $2.5062 | $475,668 | 1,419,694 (Indirect Direct) | View |
| 2014-08-29 Purchase | 2018-03-29 4:48 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 102,960 | $1.6516 | $170,046 | 1,471,174 (Indirect Direct) | View |
| 2014-08-29 Purchase | 2018-03-29 4:51 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 40,600 | $1.7809 | $72,304 | 1,491,474 (Indirect Direct) | View |
| 2016-01-27 Purchase | 2018-03-29 4:59 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT PR LLC MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 190,850 | $2.0567 | $392,528 | 1,586,899 (Indirect Direct) | View |
| 2016-01-27 Purchase | 2018-03-29 5:03 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT PR LLC MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 96,000 | $2.0067 | $192,640 | 1,634,899 (Indirect Direct) | View |
| 2016-01-27 Purchase | 2018-03-29 5:07 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT PR LLC MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 79,830 | $7.2818 | $581,310 | 2,156,797 (Indirect Direct) | View |
| 2016-01-27 Sale | 2018-03-29 5:07 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT PR LLC MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 70,100 | $9.2236 | $646,577 | 2,156,797 (Indirect Direct) | View |
| 2016-01-27 Sale | 2018-03-29 5:10 pm | FENNEC PHARMACEUTICALS Inc | FENC | MANCHESTER MANAGEMENT PR LLC MANCHESTER MANAGEMENT CO LLC Manchester Explorer L.P. BESSER JAMES E FRANK MORGAN C. 10% Owner | 914,745 | $10.61 | $9,704,024 | 1,250,000 (Indirect Direct) | View |
| 2020-04-30 Purchase | 2020-05-04 5:25 pm | FENNEC PHARMACEUTICALS Inc | FENC | Essetifin SPA CAVAZZA PAOLO Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina 10% Owner | 768,000 | $6.25 | $4,800,000 | 3,993,694 (Direct) | View |
| 2020-05-04 Purchase | 2020-05-06 4:05 pm | FENNEC PHARMACEUTICALS Inc | FENC | Southpoint Capital Advisors LP Southpoint Capital Advisors LLC Southpoint GP LP Southpoint GP LLC Clark John Smith II 10% Owner | 80,000 | $6.25 | $500,000 | 4,077,214 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-02-06 Option Award | 2018-02-08 9:02 pm | N/A 2025-02-06 | FENNEC PHARMACEUTICALS Inc | FENC | Andrade Robert CFO | 50,000 | $8.38 | 50,000 (Direct) | View |
| 2018-02-06 Option Award | 2018-02-08 9:03 pm | N/A 2025-02-06 | FENNEC PHARMACEUTICALS Inc | FENC | Raykov Rosty CEO | 100,000 | $8.38 | 100,000 (Direct) | View |
| 2018-06-08 Option Award | 2018-06-11 10:40 am | 2018-06-08 2025-06-08 | FENNEC PHARMACEUTICALS Inc | FENC | RALLIS CHRIS A Director | 20,000 | $10.93 | 20,000 (Direct) | View |
| 2018-06-08 Option Award | 2018-06-11 10:41 am | 2018-06-08 2025-06-08 | FENNEC PHARMACEUTICALS Inc | FENC | Brughera Marco Maria Director | 20,000 | $10.93 | 20,000 (Direct) | View |
| 2018-06-08 Option Award | 2018-06-11 10:43 am | 2018-06-08 2025-06-08 | FENNEC PHARMACEUTICALS Inc | FENC | Haigh Adrian Director | 20,000 | $10.93 | 20,000 (Direct) | View |
| 2018-06-08 Option Award | 2018-06-11 10:44 am | 2018-06-08 2025-06-08 | FENNEC PHARMACEUTICALS Inc | FENC | Islam Khalid Director | 25,000 | $10.93 | 25,000 (Direct) | View |
| 2018-08-15 Exercise | 2018-08-17 4:33 pm | N/A N/A | FENNEC PHARMACEUTICALS Inc | FENC | Andrade Robert CFO | 17,050 | $1.44 | 17,050 (Direct) | View |
| 2018-08-20 Exercise | 2018-08-21 3:09 pm | N/A N/A | FENNEC PHARMACEUTICALS Inc | FENC | Raykov Rosty CEO | 17,050 | $1.44 | 40,470 (Direct) | View |
| 2018-08-20 Exercise | 2018-08-22 7:46 pm | N/A N/A | FENNEC PHARMACEUTICALS Inc | FENC | Raykov Rosty CEO | 17,050 | $1.44 | 57,790 (Direct) | View |
| 2019-04-04 Option Award | 2019-04-08 11:23 am | N/A 2026-04-04 | FENNEC PHARMACEUTICALS Inc | FENC | Raykov Rosty CEO | 150,000 | $4.83 | 150,000 (Direct) | View |
| 2019-04-04 Option Award | 2019-04-08 11:28 am | N/A 2026-04-04 | FENNEC PHARMACEUTICALS Inc | FENC | Andrade Robert CFO | 80,000 | $4.83 | 80,000 (Direct) | View |
| 2019-06-18 Option Award | 2019-06-19 8:33 pm | N/A 2029-06-18 | FENNEC PHARMACEUTICALS Inc | FENC | Brughera Marco Maria Director | 20,000 | $4.26 | 20,000 (Direct) | View |
| 2019-06-18 Option Award | 2019-06-19 8:33 pm | N/A 2029-06-18 | FENNEC PHARMACEUTICALS Inc | FENC | Islam Khalid Director | 25,000 | $4.26 | 25,000 (Direct) | View |
| 2019-06-18 Option Award | 2019-06-19 8:34 pm | N/A 2029-06-18 | FENNEC PHARMACEUTICALS Inc | FENC | Haigh Adrian Director | 20,000 | $4.26 | 20,000 (Direct) | View |
| 2019-06-18 Option Award | 2019-06-19 8:34 pm | N/A 2029-06-18 | FENNEC PHARMACEUTICALS Inc | FENC | RALLIS CHRIS A Director | 20,000 | $4.26 | 20,000 (Direct) | View |
| 2019-09-09 Option Award | 2019-09-11 6:48 pm | N/A 2029-09-09 | FENNEC PHARMACEUTICALS Inc | FENC | Goel Shubh Chief Commercial Officer | 175,000 | $4.74 | 175,000 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-14 11:05 am | 2019-11-13 2029-11-13 | FENNEC PHARMACEUTICALS Inc | FENC | Cook Jodi A Director | 20,000 | $5.4 | 20,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-15 1:57 pm | N/A 2030-05-15 | FENNEC PHARMACEUTICALS Inc | FENC | Goel Shubh Chief Commercial Officer | 25,000 | $6.93 | 25,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-15 1:57 pm | N/A 2030-05-15 | FENNEC PHARMACEUTICALS Inc | FENC | Raykov Rosty CEO | 250,000 | $6.93 | 250,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-15 1:58 pm | N/A 2030-05-15 | FENNEC PHARMACEUTICALS Inc | FENC | Andrade Robert CFO | 125,000 | $6.93 | 125,000 (Direct) | View |